Common Stock, Shares, Outstanding of Syndax Pharmaceuticals Inc from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Syndax Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Syndax Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 87,405,979, a 2% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Syndax Pharmaceuticals Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 87,405,979 +1,711,536 +2% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 86,905,343 +1,334,138 +1.6% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 86,059,077 +1,030,448 +1.2% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 86,047,032 +1,067,346 +1.3% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 85,694,443 +867,811 +1% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 85,571,205 +15,933,037 +23% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 85,028,629 +15,597,431 +22% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 84,979,686 +16,484,260 +24% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 84,826,632 +16,715,247 +25% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 69,638,168 +9,515,507 +16% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 69,431,198 +13,031,464 +23% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 68,495,426 +13,464,536 +24% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 68,111,385 +13,128,280 +24% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 60,122,661 +11,272,122 +23% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 56,399,734 +7,783,106 +16% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 55,030,890 +6,782,331 +14% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 54,983,105 +7,101,882 +15% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 48,850,539 +10,016,158 +26% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 48,616,628 +10,103,884 +26% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 48,248,559 +18,007,721 +60% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 47,881,223 +20,740,739 +76% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 38,834,381 +11,693,897 +43% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 38,512,744 +11,394,798 +42% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 30,240,838 +3,145,059 +12% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 27,140,484 +2,304,533 +9.3% 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 27,140,484 +3,089,120 +13% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 27,117,946 +4,412,152 +19% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 27,095,779 +2,397,835 +9.7% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 24,835,951 +445,918 +1.8% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 24,051,364 +1,738,363 +7.8% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 22,705,794 +485,951 +2.2% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 24,697,944 +6,453,027 +35% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 24,390,033 +6,174,852 +34% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 22,313,001 +4,133,198 +23% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 22,219,843 +4,449,305 +25% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 18,244,917 +475,915 +2.7% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 18,215,181 +18,129,741 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 18,179,803 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 17,770,538 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 17,769,002 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 85,440* 31 Dec 2015 10-K 14 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.